nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—esophageal cancer	0.598	1	CbGaD
Neostigmine—BCHE—Cisplatin—esophageal cancer	0.213	0.705	CbGbCtD
Neostigmine—ABCB1—Cisplatin—esophageal cancer	0.0541	0.179	CbGbCtD
Neostigmine—ABCB1—Methotrexate—esophageal cancer	0.0351	0.116	CbGbCtD
Neostigmine—BCHE—diaphragm—esophageal cancer	0.0106	0.589	CbGeAlD
Neostigmine—Post procedural complication—Capecitabine—esophageal cancer	0.00821	0.159	CcSEcCtD
Neostigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.00259	0.0869	CbGpPWpGaD
Neostigmine—Slurred speech—Cisplatin—esophageal cancer	0.00235	0.0454	CcSEcCtD
Neostigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.00231	0.0775	CbGpPWpGaD
Neostigmine—BCHE—Irinotecan Pathway—ABCC2—esophageal cancer	0.00173	0.0583	CbGpPWpGaD
Neostigmine—Chest tightness—Capecitabine—esophageal cancer	0.00165	0.0319	CcSEcCtD
Neostigmine—ABCB1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00132	0.0445	CbGpPWpGaD
Neostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—esophageal cancer	0.00117	0.0394	CbGpPWpGaD
Neostigmine—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00115	0.0222	CcSEcCtD
Neostigmine—Laryngeal pain—Capecitabine—esophageal cancer	0.00114	0.0219	CcSEcCtD
Neostigmine—Dysarthria—Cisplatin—esophageal cancer	0.00111	0.0215	CcSEcCtD
Neostigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—esophageal cancer	0.00105	0.0351	CbGpPWpGaD
Neostigmine—Wheezing—Cisplatin—esophageal cancer	0.00102	0.0197	CcSEcCtD
Neostigmine—BCHE—bronchus—esophageal cancer	0.001	0.0553	CbGeAlD
Neostigmine—BCHE—smooth muscle tissue—esophageal cancer	0.000978	0.0542	CbGeAlD
Neostigmine—BCHE—trachea—esophageal cancer	0.000898	0.0497	CbGeAlD
Neostigmine—ACHE—lymph node—esophageal cancer	0.000898	0.0497	CbGeAlD
Neostigmine—Chest discomfort—Capecitabine—esophageal cancer	0.000875	0.0169	CcSEcCtD
Neostigmine—Lacrimation increased—Capecitabine—esophageal cancer	0.00084	0.0162	CcSEcCtD
Neostigmine—Paralysis—Methotrexate—esophageal cancer	0.000829	0.016	CcSEcCtD
Neostigmine—Dysarthria—Capecitabine—esophageal cancer	0.000818	0.0158	CcSEcCtD
Neostigmine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000813	0.0273	CbGpPWpGaD
Neostigmine—BCHE—digestive system—esophageal cancer	0.000772	0.0428	CbGeAlD
Neostigmine—Urinary incontinence—Capecitabine—esophageal cancer	0.000747	0.0144	CcSEcCtD
Neostigmine—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000725	0.0243	CbGpPWpGaD
Neostigmine—ACHE—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.0007	0.0235	CbGpPWpGaD
Neostigmine—Cramp muscle—Cisplatin—esophageal cancer	0.000686	0.0133	CcSEcCtD
Neostigmine—BCHE—lung—esophageal cancer	0.000645	0.0357	CbGeAlD
Neostigmine—Sweating increased—Cisplatin—esophageal cancer	0.000642	0.0124	CcSEcCtD
Neostigmine—Dysarthria—Methotrexate—esophageal cancer	0.000609	0.0118	CcSEcCtD
Neostigmine—ACHE—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.000606	0.0204	CbGpPWpGaD
Neostigmine—Osteoarthritis—Capecitabine—esophageal cancer	0.000562	0.0109	CcSEcCtD
Neostigmine—BCHE—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.000541	0.0182	CbGpPWpGaD
Neostigmine—Bradycardia—Cisplatin—esophageal cancer	0.000537	0.0104	CcSEcCtD
Neostigmine—Cardiac arrest—Capecitabine—esophageal cancer	0.000534	0.0103	CcSEcCtD
Neostigmine—Coma—Methotrexate—esophageal cancer	0.000526	0.0102	CcSEcCtD
Neostigmine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000521	0.0101	CcSEcCtD
Neostigmine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000518	0.01	CcSEcCtD
Neostigmine—Urethral disorder—Cisplatin—esophageal cancer	0.000517	0.00999	CcSEcCtD
Neostigmine—Flushing—Cisplatin—esophageal cancer	0.000489	0.00946	CcSEcCtD
Neostigmine—ABCB1—epithelium—esophageal cancer	0.000484	0.0268	CbGeAlD
Neostigmine—Bronchospasm—Capecitabine—esophageal cancer	0.000478	0.00923	CcSEcCtD
Neostigmine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000475	0.00918	CcSEcCtD
Neostigmine—Sweating increased—Capecitabine—esophageal cancer	0.000473	0.00914	CcSEcCtD
Neostigmine—Arrhythmia—Cisplatin—esophageal cancer	0.000471	0.0091	CcSEcCtD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000467	0.0157	CbGpPWpGaD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000467	0.0157	CbGpPWpGaD
Neostigmine—Flatulence—Cisplatin—esophageal cancer	0.000452	0.00874	CcSEcCtD
Neostigmine—Muscle spasms—Cisplatin—esophageal cancer	0.000441	0.00853	CcSEcCtD
Neostigmine—BCHE—lymph node—esophageal cancer	0.000441	0.0244	CbGeAlD
Neostigmine—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000437	0.0147	CbGpPWpGaD
Neostigmine—ABCB1—trachea—esophageal cancer	0.000428	0.0237	CbGeAlD
Neostigmine—Osteoarthritis—Methotrexate—esophageal cancer	0.000418	0.00808	CcSEcCtD
Neostigmine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000416	0.014	CbGpPWpGaD
Neostigmine—Convulsion—Cisplatin—esophageal cancer	0.000398	0.00769	CcSEcCtD
Neostigmine—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000398	0.0134	CbGpPWpGaD
Neostigmine—Bradycardia—Capecitabine—esophageal cancer	0.000396	0.00765	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000388	0.0075	CcSEcCtD
Neostigmine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000384	0.00742	CcSEcCtD
Neostigmine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000382	0.00738	CcSEcCtD
Neostigmine—Urethral disorder—Capecitabine—esophageal cancer	0.000381	0.00736	CcSEcCtD
Neostigmine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000375	0.00724	CcSEcCtD
Neostigmine—ABCB1—digestive system—esophageal cancer	0.000368	0.0204	CbGeAlD
Neostigmine—Nervous system disorder—Cisplatin—esophageal cancer	0.000367	0.0071	CcSEcCtD
Neostigmine—Tachycardia—Cisplatin—esophageal cancer	0.000366	0.00707	CcSEcCtD
Neostigmine—Skin disorder—Cisplatin—esophageal cancer	0.000364	0.00703	CcSEcCtD
Neostigmine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000362	0.007	CcSEcCtD
Neostigmine—Flushing—Capecitabine—esophageal cancer	0.000361	0.00697	CcSEcCtD
Neostigmine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00035	0.00677	CcSEcCtD
Neostigmine—Hypotension—Cisplatin—esophageal cancer	0.00035	0.00677	CcSEcCtD
Neostigmine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000349	0.0117	CbGpPWpGaD
Neostigmine—Arrhythmia—Capecitabine—esophageal cancer	0.000347	0.00671	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000341	0.0066	CcSEcCtD
Neostigmine—Mental disorder—Capecitabine—esophageal cancer	0.000341	0.00658	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000338	0.0114	CbGpPWpGaD
Neostigmine—Dyspnoea—Cisplatin—esophageal cancer	0.000334	0.00645	CcSEcCtD
Neostigmine—Flatulence—Capecitabine—esophageal cancer	0.000333	0.00644	CcSEcCtD
Neostigmine—Muscle spasms—Capecitabine—esophageal cancer	0.000325	0.00629	CcSEcCtD
Neostigmine—ACHE—Peptide hormone metabolism—GHRL—esophageal cancer	0.000324	0.0109	CbGpPWpGaD
Neostigmine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000323	0.00625	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—esophageal cancer	0.000322	0.00623	CcSEcCtD
Neostigmine—ABCB1—lung—esophageal cancer	0.000307	0.017	CbGeAlD
Neostigmine—Syncope—Capecitabine—esophageal cancer	0.000303	0.00586	CcSEcCtD
Neostigmine—Loss of consciousness—Capecitabine—esophageal cancer	0.000297	0.00575	CcSEcCtD
Neostigmine—BCHE—Peptide hormone metabolism—GHRL—esophageal cancer	0.000289	0.0097	CbGpPWpGaD
Neostigmine—Arthralgia—Capecitabine—esophageal cancer	0.000288	0.00557	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000286	0.00553	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000286	0.00552	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—esophageal cancer	0.000284	0.00548	CcSEcCtD
Neostigmine—Dry mouth—Capecitabine—esophageal cancer	0.000282	0.00544	CcSEcCtD
Neostigmine—Hypersensitivity—Cisplatin—esophageal cancer	0.000276	0.00533	CcSEcCtD
Neostigmine—Shock—Capecitabine—esophageal cancer	0.000272	0.00525	CcSEcCtD
Neostigmine—Nervous system disorder—Capecitabine—esophageal cancer	0.000271	0.00523	CcSEcCtD
Neostigmine—Tachycardia—Capecitabine—esophageal cancer	0.000269	0.00521	CcSEcCtD
Neostigmine—Asthenia—Cisplatin—esophageal cancer	0.000269	0.00519	CcSEcCtD
Neostigmine—Skin disorder—Capecitabine—esophageal cancer	0.000268	0.00518	CcSEcCtD
Neostigmine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000267	0.00516	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000263	0.00883	CbGpPWpGaD
Neostigmine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000261	0.00504	CcSEcCtD
Neostigmine—Hypotension—Capecitabine—esophageal cancer	0.000258	0.00499	CcSEcCtD
Neostigmine—Diarrhoea—Cisplatin—esophageal cancer	0.000256	0.00495	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—esophageal cancer	0.000253	0.0049	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000252	0.00486	CcSEcCtD
Neostigmine—Insomnia—Capecitabine—esophageal cancer	0.00025	0.00483	CcSEcCtD
Neostigmine—Dyspnoea—Capecitabine—esophageal cancer	0.000246	0.00476	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—NOS2—esophageal cancer	0.000243	0.00816	CbGpPWpGaD
Neostigmine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000238	0.00461	CcSEcCtD
Neostigmine—Vomiting—Cisplatin—esophageal cancer	0.000238	0.0046	CcSEcCtD
Neostigmine—Rash—Cisplatin—esophageal cancer	0.000236	0.00456	CcSEcCtD
Neostigmine—Dermatitis—Cisplatin—esophageal cancer	0.000236	0.00456	CcSEcCtD
Neostigmine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000226	0.00436	CcSEcCtD
Neostigmine—Nausea—Cisplatin—esophageal cancer	0.000223	0.0043	CcSEcCtD
Neostigmine—Urticaria—Capecitabine—esophageal cancer	0.000219	0.00424	CcSEcCtD
Neostigmine—Abdominal pain—Capecitabine—esophageal cancer	0.000218	0.00422	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—esophageal cancer	0.000218	0.00422	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—RB1—esophageal cancer	0.000217	0.0073	CbGpPWpGaD
Neostigmine—Arthralgia—Methotrexate—esophageal cancer	0.000214	0.00414	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000213	0.00412	CcSEcCtD
Neostigmine—ABCB1—lymph node—esophageal cancer	0.00021	0.0116	CbGeAlD
Neostigmine—ACHE—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00021	0.00706	CbGpPWpGaD
Neostigmine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000206	0.00397	CcSEcCtD
Neostigmine—Hypersensitivity—Capecitabine—esophageal cancer	0.000203	0.00393	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—esophageal cancer	0.000202	0.0039	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—esophageal cancer	0.0002	0.00386	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000199	0.00384	CcSEcCtD
Neostigmine—Asthenia—Capecitabine—esophageal cancer	0.000198	0.00383	CcSEcCtD
Neostigmine—ACHE—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000197	0.00662	CbGpPWpGaD
Neostigmine—Pruritus—Capecitabine—esophageal cancer	0.000195	0.00378	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—esophageal cancer	0.000192	0.00371	CcSEcCtD
Neostigmine—Diarrhoea—Capecitabine—esophageal cancer	0.000189	0.00365	CcSEcCtD
Neostigmine—ACHE—ATF-2 transcription factor network—BCL2—esophageal cancer	0.000188	0.00632	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000188	0.0063	CbGpPWpGaD
Neostigmine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000187	0.00362	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—esophageal cancer	0.000186	0.00359	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000186	0.00623	CbGpPWpGaD
Neostigmine—Dyspnoea—Methotrexate—esophageal cancer	0.000183	0.00354	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—esophageal cancer	0.000183	0.00353	CcSEcCtD
Neostigmine—Dizziness—Capecitabine—esophageal cancer	0.000183	0.00353	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000179	0.006	CbGpPWpGaD
Neostigmine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000177	0.00343	CcSEcCtD
Neostigmine—BCHE—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000176	0.0059	CbGpPWpGaD
Neostigmine—Vomiting—Capecitabine—esophageal cancer	0.000176	0.00339	CcSEcCtD
Neostigmine—Rash—Capecitabine—esophageal cancer	0.000174	0.00336	CcSEcCtD
Neostigmine—Dermatitis—Capecitabine—esophageal cancer	0.000174	0.00336	CcSEcCtD
Neostigmine—Headache—Capecitabine—esophageal cancer	0.000173	0.00334	CcSEcCtD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.00017	0.00572	CbGpPWpGaD
Neostigmine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000168	0.00325	CcSEcCtD
Neostigmine—Nausea—Capecitabine—esophageal cancer	0.000164	0.00317	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000163	0.00549	CbGpPWpGaD
Neostigmine—Urticaria—Methotrexate—esophageal cancer	0.000163	0.00316	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—esophageal cancer	0.000162	0.00314	CcSEcCtD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000162	0.00546	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—CCND1—esophageal cancer	0.000161	0.00542	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—GNG7—esophageal cancer	0.000161	0.00541	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000155	0.00522	CbGpPWpGaD
Neostigmine—Hypersensitivity—Methotrexate—esophageal cancer	0.000151	0.00293	CcSEcCtD
Neostigmine—ACHE—Neuronal System—ALDH2—esophageal cancer	0.000151	0.00507	CbGpPWpGaD
Neostigmine—ACHE—ATF-2 transcription factor network—EP300—esophageal cancer	0.000149	0.00499	CbGpPWpGaD
Neostigmine—Asthenia—Methotrexate—esophageal cancer	0.000147	0.00285	CcSEcCtD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000147	0.00495	CbGpPWpGaD
Neostigmine—Pruritus—Methotrexate—esophageal cancer	0.000145	0.00281	CcSEcCtD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000145	0.00487	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—GNG7—esophageal cancer	0.000144	0.00483	CbGpPWpGaD
Neostigmine—Diarrhoea—Methotrexate—esophageal cancer	0.000141	0.00272	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—esophageal cancer	0.000136	0.00263	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000135	0.00455	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—ALDH2—esophageal cancer	0.000135	0.00452	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000132	0.00442	CbGpPWpGaD
Neostigmine—Vomiting—Methotrexate—esophageal cancer	0.000131	0.00253	CcSEcCtD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.00013	0.00436	CbGpPWpGaD
Neostigmine—Rash—Methotrexate—esophageal cancer	0.00013	0.0025	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—esophageal cancer	0.000129	0.0025	CcSEcCtD
Neostigmine—Headache—Methotrexate—esophageal cancer	0.000129	0.00249	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000128	0.00428	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000128	0.00428	CbGpPWpGaD
Neostigmine—Nausea—Methotrexate—esophageal cancer	0.000122	0.00236	CcSEcCtD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000121	0.00405	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—XBP1—esophageal cancer	0.000119	0.00401	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000114	0.00384	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000114	0.00384	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00011	0.00369	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—XBP1—esophageal cancer	0.000106	0.00358	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000106	0.00357	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000103	0.00346	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—SLC30A7—esophageal cancer	0.000102	0.00343	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	9.79e-05	0.00329	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	9.67e-05	0.00325	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.57e-05	0.00322	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—ST6GAL1—esophageal cancer	9.19e-05	0.00309	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	8.68e-05	0.00292	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	8.56e-05	0.00288	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	8.54e-05	0.00287	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	8.52e-05	0.00286	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BLVRB—esophageal cancer	8.51e-05	0.00286	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC52A3—esophageal cancer	8.51e-05	0.00286	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	7.78e-05	0.00261	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.61e-05	0.00256	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—BLVRB—esophageal cancer	7.59e-05	0.00255	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC52A3—esophageal cancer	7.59e-05	0.00255	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	7.55e-05	0.00254	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	7.35e-05	0.00247	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC10A2—esophageal cancer	7.23e-05	0.00243	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CA1—esophageal cancer	7.23e-05	0.00243	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	7.14e-05	0.0024	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	7.11e-05	0.00239	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—ACTB—esophageal cancer	7.1e-05	0.00238	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.98e-05	0.00234	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.79e-05	0.00228	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	6.76e-05	0.00227	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	6.72e-05	0.00226	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CA2—esophageal cancer	6.62e-05	0.00222	CbGpPWpGaD
Neostigmine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	6.54e-05	0.0022	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.47e-05	0.00217	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC10A2—esophageal cancer	6.45e-05	0.00217	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA1—esophageal cancer	6.45e-05	0.00217	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—HSPA5—esophageal cancer	6.41e-05	0.00215	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—ACTB—esophageal cancer	6.33e-05	0.00213	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	6.32e-05	0.00212	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.31e-05	0.00212	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CALR—esophageal cancer	6.21e-05	0.00209	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADH7—esophageal cancer	6.15e-05	0.00207	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PLCE1—esophageal cancer	6.15e-05	0.00207	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—GHRL—esophageal cancer	6.11e-05	0.00205	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	6.1e-05	0.00205	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.08e-05	0.00204	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—FBXW7—esophageal cancer	6.01e-05	0.00202	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	5.99e-05	0.00201	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	5.91e-05	0.00199	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CA2—esophageal cancer	5.9e-05	0.00198	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.81e-05	0.00195	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.77e-05	0.00194	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	5.73e-05	0.00193	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—HSPA5—esophageal cancer	5.72e-05	0.00192	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	5.72e-05	0.00192	CbGpPWpGaD
Neostigmine—ACHE—Phospholipid metabolism—PIK3CA—esophageal cancer	5.57e-05	0.00187	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	5.55e-05	0.00186	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CALR—esophageal cancer	5.54e-05	0.00186	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLCE1—esophageal cancer	5.49e-05	0.00184	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADH7—esophageal cancer	5.49e-05	0.00184	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	5.48e-05	0.00184	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	5.48e-05	0.00184	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—GHRL—esophageal cancer	5.45e-05	0.00183	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.42e-05	0.00182	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADH1B—esophageal cancer	5.39e-05	0.00181	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—FBXW7—esophageal cancer	5.36e-05	0.0018	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	5.25e-05	0.00176	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TYMP—esophageal cancer	5.15e-05	0.00173	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	5.06e-05	0.0017	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP26A1—esophageal cancer	5.01e-05	0.00168	CbGpPWpGaD
Neostigmine—BCHE—Phospholipid metabolism—PIK3CA—esophageal cancer	4.97e-05	0.00167	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.95e-05	0.00166	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALOX15—esophageal cancer	4.89e-05	0.00164	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADH1B—esophageal cancer	4.81e-05	0.00162	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTO1—esophageal cancer	4.66e-05	0.00157	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TPI1—esophageal cancer	4.66e-05	0.00157	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TYMP—esophageal cancer	4.6e-05	0.00154	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP26A1—esophageal cancer	4.47e-05	0.0015	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDOB—esophageal cancer	4.47e-05	0.0015	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALOX15—esophageal cancer	4.36e-05	0.00146	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GAPDH—esophageal cancer	4.3e-05	0.00145	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.29e-05	0.00144	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CRABP1—esophageal cancer	4.26e-05	0.00143	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTO1—esophageal cancer	4.16e-05	0.0014	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TPI1—esophageal cancer	4.16e-05	0.0014	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.15e-05	0.0014	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.15e-05	0.0014	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNG7—esophageal cancer	4.06e-05	0.00136	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDOB—esophageal cancer	3.99e-05	0.00134	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GAPDH—esophageal cancer	3.84e-05	0.00129	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CRABP1—esophageal cancer	3.8e-05	0.00128	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDH2—esophageal cancer	3.8e-05	0.00128	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.77e-05	0.00127	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	3.73e-05	0.00125	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	3.71e-05	0.00125	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC52A3—esophageal cancer	3.7e-05	0.00124	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BLVRB—esophageal cancer	3.7e-05	0.00124	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNG7—esophageal cancer	3.62e-05	0.00122	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—esophageal cancer	3.61e-05	0.00121	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2A6—esophageal cancer	3.57e-05	0.0012	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.56e-05	0.0012	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDH2—esophageal cancer	3.39e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS1—esophageal cancer	3.39e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ENO1—esophageal cancer	3.39e-05	0.00114	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PSME2—esophageal cancer	3.34e-05	0.00112	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PSME1—esophageal cancer	3.34e-05	0.00112	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—esophageal cancer	3.22e-05	0.00108	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.2e-05	0.00107	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2A6—esophageal cancer	3.19e-05	0.00107	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.18e-05	0.00107	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.15e-05	0.00106	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA1—esophageal cancer	3.15e-05	0.00106	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.11e-05	0.00104	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.04e-05	0.00102	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS1—esophageal cancer	3.02e-05	0.00102	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ENO1—esophageal cancer	3.02e-05	0.00102	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PSME2—esophageal cancer	2.98e-05	0.001	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PSME1—esophageal cancer	2.98e-05	0.001	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.91e-05	0.000979	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1B1—esophageal cancer	2.88e-05	0.000968	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA2—esophageal cancer	2.88e-05	0.000968	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.75e-05	0.000922	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP19A1—esophageal cancer	2.71e-05	0.00091	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLCE1—esophageal cancer	2.68e-05	0.000899	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADH7—esophageal cancer	2.68e-05	0.000899	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.66e-05	0.000892	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.6e-05	0.000874	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1B1—esophageal cancer	2.57e-05	0.000863	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.53e-05	0.000849	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMOX1—esophageal cancer	2.47e-05	0.00083	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.42e-05	0.000814	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP19A1—esophageal cancer	2.42e-05	0.000812	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCB1—esophageal cancer	2.37e-05	0.000797	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADH1B—esophageal cancer	2.35e-05	0.000789	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.3e-05	0.000771	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TYMP—esophageal cancer	2.24e-05	0.000754	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMOX1—esophageal cancer	2.2e-05	0.000741	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.2e-05	0.00074	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.18e-05	0.000733	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.16e-05	0.000726	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.15e-05	0.000724	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALOX15—esophageal cancer	2.13e-05	0.000715	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCB1—esophageal cancer	2.12e-05	0.000711	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTO1—esophageal cancer	2.03e-05	0.000682	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TPI1—esophageal cancer	2.03e-05	0.000682	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDOB—esophageal cancer	1.95e-05	0.000654	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GAPDH—esophageal cancer	1.87e-05	0.000629	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.87e-05	0.000628	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CRABP1—esophageal cancer	1.86e-05	0.000623	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.81e-05	0.000607	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.79e-05	0.000602	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNG7—esophageal cancer	1.77e-05	0.000593	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDH2—esophageal cancer	1.65e-05	0.000556	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.6e-05	0.000537	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CREBBP—esophageal cancer	1.59e-05	0.000533	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—esophageal cancer	1.57e-05	0.000529	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.56e-05	0.000522	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENO1—esophageal cancer	1.47e-05	0.000495	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS1—esophageal cancer	1.47e-05	0.000495	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.47e-05	0.000495	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PSME2—esophageal cancer	1.45e-05	0.000488	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PSME1—esophageal cancer	1.45e-05	0.000488	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NOS3—esophageal cancer	1.42e-05	0.000477	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CREBBP—esophageal cancer	1.41e-05	0.000475	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—esophageal cancer	1.3e-05	0.000436	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NOS3—esophageal cancer	1.27e-05	0.000425	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.25e-05	0.000421	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.18e-05	0.000396	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—esophageal cancer	1.16e-05	0.000389	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—EP300—esophageal cancer	1.08e-05	0.000363	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.08e-05	0.000361	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—EP300—esophageal cancer	9.63e-06	0.000324	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—esophageal cancer	7.99e-06	0.000268	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—esophageal cancer	7.12e-06	0.000239	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CREBBP—esophageal cancer	6.9e-06	0.000232	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NOS3—esophageal cancer	6.18e-06	0.000208	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—esophageal cancer	5.65e-06	0.00019	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—EP300—esophageal cancer	4.7e-06	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.48e-06	0.000117	CbGpPWpGaD
